DESCRIPTION (provided by applicant): Currently, more than 60 % of end-stage renal diseases patients who require chronic hemodialysis are accessed through a native arteriovenous fistula (AVF) or synthe ...SBIR Phase II 2012 Department of Health and Human Services
DESCRIPTION (provided by applicant): Thromboembolic disorders are major causes of morbidity and mortality in the Western societies. Anticoagulants are pivotal agents in the prevention and treatment of ...SBIR Phase I 2009 Department of Health and Human Services
DESCRIPTION (provided by applicant): Phase I: Clot formation in the blood vessel (thrombosis) causes a broad range of serious clinical conditions, such as unstable angina, acute myocardial infarction, ...SBIR Phase I 2005 Department of Health and Human Services
EVAS THERAPEUTICS, LLC.
| 613 HUNTLEY HEIGHTS DRIVE
BALLWIN, MO, -
|Socially and Economically Disadvantaged:||N|
|Number of Employees:||n/a|